Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01845857 · ClinicalTrials.gov registry record · NA

A National Study of the Chronic Disease Self-Management Program

A NA study of Diabetes Mellitus, Type 2 and Chronic Disease, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
1,170
Enrollment target
1
Study location

NCT01845857: Completed NA study of Diabetes Mellitus, Type 2 and Chronic Disease, sponsored by Stanford University.

NCT01845857 is a NA study of Diabetes Mellitus, Type 2 and Chronic Disease that has completed, run by Stanford University. The registered enrollment target is 1,170 participants, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01845857, a NA study of Diabetes Mellitus, Type 2 and Chronic Disease, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
1,170 participants
Enrollment target
1
Study location

Study Summary

This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains maintained over a six and twelve month period? Can critical clinical changes be seen for those who are diabetic?

Interventions

  • BEHAVIORAL Chronic Disease Self-Management Workshop

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 1,170 participants
Start Date 2010-08
Est. Completion 2013-04
Phase NA
Stanford University

1,744 total trials

What the finished NCT01845857 record still lists

NCT01845857 is an interventional study that assigns participants to a tested intervention. Its 1,170 participants enrollment target places it among the larger protocols in the corpus, below the 4,482-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Chronic Disease Self-Management Workshop is the first listed.

NCT01845857 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01845857 about?

NCT01845857 is a clinical study titled "A National Study of the Chronic Disease Self-Management Program". This survey will address important research, practice, and policy questions: How does Chronic Disease Self-Management Program (CDSMP) impact participants' general health, their health behaviors, and their need for health care utilization? Who benefits most from the CDSMP program? Are predicted gains...

What is the current status of trial NCT01845857?

This trial is currently completed. It is a NA study. The enrollment target is 1,170 participants. The study started on 2010-08. Estimated completion is 2013-04.

What conditions does trial NCT01845857 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Chronic Disease.

What interventions are being tested in trial NCT01845857?

The interventions under investigation include: Chronic Disease Self-Management Workshop (BEHAVIORAL).

Who is sponsoring clinical trial NCT01845857?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01845857 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01845857's enrollment target sits among peer trials

1,170 29th of 348 higher than 320 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06469788 · 1,170 participants · NA

    Testimonials and Navigation in Rheumatology

  • NCT04275557 · 1,174 participants

    Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

  • NCT07009509 · 1,166 participants · NA

    Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping

  • NCT06133322 · 1,176 participants · NA

    Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01845857, the US trial registry maintained by the National Library of Medicine. NCT01845857 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.